Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1060 studies found for:    "Hepatitis B"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Antigen-specific Immune Response to Hepatitis B Virus in Utero
Condition: Hepatitis B
Intervention:
2 Unknown  Apoptosis and Hepatitis B: The Role of Apoptosis in Patients Who Are HBeAg Negative
Condition: Hepatitis B
Intervention:
3 Completed
Has Results
Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen (HBsAg)
Condition: Hepatitis B
Intervention: Procedure: Blood sampling
4 Completed
Has Results
Effectiveness of Two Hepatitis B Vaccines in HIV-negative Youths
Condition: Hepatitis B
Interventions: Biological: Recombivax;   Biological: Twinrix
5 Completed Increasing Hepatitis B Screening Among Korean Church Attendees
Condition: Hepatitis B
Intervention: Behavioral: Educational Small Group Session
6 Completed
Has Results
LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ Mothers
Condition: Hepatitis B
Interventions: Biological: Engerix™ -B;   Biological: Hepatitis B immunoglobulin (HBIg)
7 Recruiting Hepatitis B Research Network Pediatric Cohort Study (HBRN)
Condition: Hepatitis B
Intervention:
8 Completed Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib
Condition: Hepatitis B
Intervention: Biological: hepatitis B vaccine
9 Completed Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib
Condition: Hepatitis B
Intervention: Biological: hepatitis B vaccine
10 Completed Hepatitis B Booster Study in Adolescence
Condition: Hepatitis B
Intervention:
11 Unknown  Efficacy of Peg-interferon α-2a in Hepatitis B Patients Treated by Entecavir Without HBeAg Loss
Condition: Hepatitis B
Interventions: Drug: Entecavir;   Drug: Peginterferon alfa-2a
12 Recruiting Hepatitis B Research Network Adult Cohort Study
Condition: Hepatitis B
Intervention:
13 Completed
Has Results
Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine
Condition: Hepatitis B
Interventions: Biological: Engerix-B™;   Biological: Fendrix™;   Biological: GSK Biologicals' Hepatitis B vaccines (GSK223192A);   Biological: HBsAg (Booster injection)
14 Unknown  A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.
Condition: Hepatitis B
Intervention: Drug: clevudine (drug)
15 Completed
Has Results
Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine.
Condition: Hepatitis B
Intervention: Biological: Engerix™-B
16 Completed Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT
Condition: Hepatitis B
Interventions: Drug: Hepsera;   Drug: Hepsera and lamivudine
17 Completed
Has Results
Follow-up Study 16-20 Years After Primary Vaccination Against Hepatitis B of Newborns From HBeAg+ & HBsAg+ Mothers
Condition: Hepatitis B
Intervention: Biological: Engerix™-B
18 Recruiting "Real-life" Cohort of Patients With Chronic Hepatitis B Virus Infection
Condition: Hepatitis B
Intervention:
19 Completed Hepatitis B Vaccination Through Syringe Exchange Programs: A Randomized, Controlled Trial of Vaccination Schedules
Condition: Hepatitis B
Intervention: Biological: Vaccination to prevent hepatitis B virus infection
20 Completed Comparison of Immuno, Reacto and Safety of Recombinant Hepatitis B Vaccine With or Without MPL in Healthy Older Adults
Condition: Hepatitis B
Interventions: Biological: Engerix™-B;   Biological: Recombinant HBsAg with different concentrations of Aluminium Salts and/or MPL

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.